Heart failure: The many faces of heart failure with preserved ejection fraction

Nature Reviews Cardiology

Volumn 9, Issue 10, 2012, Pages 555-556

  Shah, Amil M ^a   Pfeffer, Marc A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE;

CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIASTOLIC DYSFUNCTION; DRUG EFFICACY; HEART FAILURE; HEART FAILURE AND PRESERVED EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HUMAN; IMAGE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; ARTICLE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; PATHOLOGY; PROGNOSIS;

HEART FAILURE; HUMANS; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84866731794     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.123     Document Type: Review

References (10)

1. Patel, K. et al. Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study. Eur. J. Heart Fail. http://dx.doi.org/10.1093/eurjhf/hfs101.
2. Dougherty, A. H., Naccarelli, G. V., Gray, E. L., Hicks, C. H. & Goldstein, R. A. Congestive heart failure with normal systolic function. Am. J. Cardiol. 54, 778-782 (1984).
3. Lam, C. S. P., Donal, E., Kraigher-Krainer, E. & Vasan, R. S. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur. J. Heart Fail. 13, 18-28 (2011).
4. Borlaug, B. A. & Paulus, W. J. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur. Heart J. 32, 670-679 (2011).
5. McMurray, J. J. V. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33, 1787-1847 (2012).
6. Solomon, S. D. et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116, 1482-1487 (2007).
7. Zile, M. R. et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124, 2491-2501 (2011).
8. Lam, C. S. P. et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115, 1982-1990 (2007).
9. Persson, H. et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J. Am. Coll. Cardiol. 49, 687-694 (2007).
10. Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289, 194-202 (2003).